Ecuphar GmbH, based in Greifswald, develops, manufactures and distributes products in the veterinary sector, particularly veterinary medicinal products. The sole shareholder is Ecuphar N.V., Oostkamp (Belgium), as stated in the notes. In the 2023 financial year the company reported a gross result of EUR 7,825,156.91; at the same time there was an annual deficit of EUR 192,619.01 and a reported retained profit of EUR 2,121,700.82. The average number of employees during the financial year was 39.2. The company is a small company under § 267 (1) HGB and is therefore not required to publish a profit-and-loss statement.
die Entwicklung, die Herstellung und der Vertrieb von Produkten des Veterinärbereiches, insbesondere veterinärmedizinischer Produkte
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Stralsund Local Court, HRB 8165 (as of 3 October 2026)
Source: German Commercial Register (Handelsregister) Stralsund Local Court, HRB 8165 (as of 3 October 2026)
Source: German Commercial Register (Handelsregister) Stralsund Local Court, HRB 8165 (as of 3 October 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Stralsund Local Court, HRB 8165 (as of 3 October 2026)
Tilray Deutschland GmbH
Densborn · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
INTERSERO GmbH
Walluf · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
A.R.C.O.-Chemie GmbH
Herdecke · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Sign in to view detailed salary and cost trends.
